Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R21-Matrix-M vaccination synchronized with seasonal malaria chemoprevention versus routine EPI delivery in Chad
PACTR202506716081750Phase 4Not yet recruiting
- Sponsor
- Médecins Sans Frontières
- Start
- Jul 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in malaria (2 arms), sponsored by Médecins Sans Frontières. Primary endpoint: Malaria incidence non-inferiority. Planned start Jul 2025; status: not yet recruiting.
02
Conditions
malaria
Beyond the preview
Go deeper on PACTR202506716081750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202506716081750.